LivaNova (LIVN) Return on Invested Capital (2016 - 2026)
LivaNova (LIVN) reported Return on Invested Capital of 0.01% for Q1 2026, little changed on a YoY basis from 0.01% in Q1 2025, and down 6.75% sequentially from 0.01% in Q4 2025.
LivaNova (LIVN) Return on Invested Capital (2016 - 2026) Analysis & Trends
LivaNova (LIVN) has 11 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.03%, up 1.0% from the prior year.
- Return on Invested Capital fell to 0.01% in Q1 2026, from 0.01% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2025 to a low of 0.02% in Q1 2023.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
- Across the five-year window, Return on Invested Capital grew 2 bps in 2022 and slipped 2 bps in 2023, its largest moves.
- Tracing LIVN's Return on Invested Capital over 5 years: stood at 0.01% in 2022, then surged by 133 bps to 0.0% in 2023, then soared by 361 bps to 0.01% in 2024, then decreased by 17 bps to 0.01% in 2025, then slipped by 7 bps to 0.01% in 2026.
- Business Quant data shows LIVN's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 0.01% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 0.01% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 0.00% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 0.00% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 0.00% |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.02% |